343 related articles for article (PubMed ID: 6883184)
1. Comparative effects of phenylbutazone, naproxen and flunixin meglumine on equine platelet aggregation and platelet factor 3 availability in vitro.
Johnstone IB
Can J Comp Med; 1983 Apr; 47(2):172-9. PubMed ID: 6883184
[TBL] [Abstract][Full Text] [Related]
2. Phenylbutazone inhibition of equine platelet function.
Meyers KM; Lindner C; Katz J; Grant B
Am J Vet Res; 1979 Feb; 40(2):265-70. PubMed ID: 464364
[TBL] [Abstract][Full Text] [Related]
3. Effects of phenylbutazone alone or in combination with flunixin meglumine on blood protein concentrations in horses.
Reed SK; Messer NT; Tessman RK; Keegan KG
Am J Vet Res; 2006 Mar; 67(3):398-402. PubMed ID: 16506899
[TBL] [Abstract][Full Text] [Related]
4. Serum thromboxane in the horse and its inhibition by aspirin, phenylbutazone and flunixin.
Lees P; Ewins CP; Taylor JB; Sedgwick AD
Br Vet J; 1987; 143(5):462-76. PubMed ID: 3119142
[No Abstract] [Full Text] [Related]
5. Effects of Firocoxib, Flunixin Meglumine, and Phenylbutazone on Platelet Function and Thromboxane Synthesis in Healthy Horses.
Burkett BN; Thomason JM; Hurdle HM; Wills RW; Fontenot RL
Vet Surg; 2016 Nov; 45(8):1087-1094. PubMed ID: 27731498
[TBL] [Abstract][Full Text] [Related]
6. Modulation of arachidonic acid metabolism in endotoxic horses: comparison of flunixin meglumine, phenylbutazone, and a selective thromboxane synthetase inhibitor.
Moore JN; Hardee MM; Hardee GE
Am J Vet Res; 1986 Jan; 47(1):110-3. PubMed ID: 3080926
[TBL] [Abstract][Full Text] [Related]
7. Effects of concurrent administration of phenylbutazone and flunixin meglumine on pharmacokinetic variables and in vitro generation of thromboxane B2 in mares.
Semrad SD; Sams RA; Harris ON; Ashcraft SM
Am J Vet Res; 1993 Nov; 54(11):1901-5. PubMed ID: 8291770
[TBL] [Abstract][Full Text] [Related]
8. Experimental uses of flunixin meglumine and phenylbutazone in food-producing animals.
Kopcha M; Ahl AS
J Am Vet Med Assoc; 1989 Jan; 194(1):45-9. PubMed ID: 2644181
[TBL] [Abstract][Full Text] [Related]
9. The effect of oral phenylbutazone on whole blood platelet aggregation in the dog.
Jackson ML; Searcy GP; Olexson DW
Can J Comp Med; 1985 Jul; 49(3):271-7. PubMed ID: 3930056
[TBL] [Abstract][Full Text] [Related]
10. Effects of flunixin meglumine, phenylbutazone and a selective thromboxane synthetase inhibitor (UK-38,485) on thromboxane and prostacyclin production in healthy horses.
Hardee MM; Moore JN; Hardee GE
Res Vet Sci; 1986 Mar; 40(2):152-6. PubMed ID: 3517992
[TBL] [Abstract][Full Text] [Related]
11. Platelet-activating factor and not thromboxane A2 is an important mediator of endotoxin-induced platelet aggregation in equine heparinised whole blood in vitro.
Jarvis GE; Evans RJ
Blood Coagul Fibrinolysis; 1996 Mar; 7(2):194-8. PubMed ID: 8735817
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the equine platelet aggregation response.
Meyers KM; Lindner C; Grant B
Am J Vet Res; 1979 Feb; 40(2):260-4. PubMed ID: 464363
[TBL] [Abstract][Full Text] [Related]
13. In vitro effects of cyclooxygenase inhibitors in whole blood of horses, dogs, and cats.
Brideau C; Van Staden C; Chan CC
Am J Vet Res; 2001 Nov; 62(11):1755-60. PubMed ID: 11703020
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the ability of carprofen and flunixin meglumine to inhibit activation of nuclear factor kappa B.
Bryant CE; Farnfield BA; Janicke HJ
Am J Vet Res; 2003 Feb; 64(2):211-5. PubMed ID: 12602591
[TBL] [Abstract][Full Text] [Related]
15. COX-1 and COX-2 inhibition in horse blood by phenylbutazone, flunixin, carprofen and meloxicam: an in vitro analysis.
Beretta C; Garavaglia G; Cavalli M
Pharmacol Res; 2005 Oct; 52(4):302-6. PubMed ID: 15939622
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of the enzymes responsible for the metabolism of the non-steroidal anti-inflammatory drugs, flunixin meglumine and phenylbutazone, in horses.
Knych HK; Finno CJ; Baden R; Arthur RM; McKemie DS
J Vet Pharmacol Ther; 2021 Jan; 44(1):36-46. PubMed ID: 32757313
[TBL] [Abstract][Full Text] [Related]
17. Use of force plate analysis to compare the analgesic effects of intravenous administration of phenylbutazone and flunixin meglumine in horses with navicular syndrome.
Erkert RS; MacAllister CG; Payton ME; Clarke CR
Am J Vet Res; 2005 Feb; 66(2):284-8. PubMed ID: 15757129
[TBL] [Abstract][Full Text] [Related]
18. Comparison of adverse effects of phenylbutazone, flunixin meglumine, and ketoprofen in horses.
MacAllister CG; Morgan SJ; Borne AT; Pollet RA
J Am Vet Med Assoc; 1993 Jan; 202(1):71-7. PubMed ID: 8420909
[TBL] [Abstract][Full Text] [Related]
19. Actions of non-steroidal anti-inflammatory drugs on equine leucocyte movement in vitro.
Dawson J; Lees P; Sedgwick AD
J Vet Pharmacol Ther; 1987 Jun; 10(2):150-9. PubMed ID: 3612943
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of administration of phenylbutazone alone or concurrent administration of phenylbutazone and flunixin meglumine to alleviate lameness in horses.
Keegan KG; Messer NT; Reed SK; Wilson DA; Kramer J
Am J Vet Res; 2008 Feb; 69(2):167-73. PubMed ID: 18241011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
